One study reported that serum levels of polymeric immunoglobulin receptor (PIGR) are downregulated in NPC patients, and low levels of the PIGR expression are strongly related to advanced clinical stages and to worse overall survival, making this useful as a prognosis biomarker. This evidence concerns the gene PIGR and nasopharyngeal carcinoma.